Pasta, A.; Calabrese, F.; Marabotto, E.; Furnari, M.; Demarzo, M.G.; Pellegrino, R.; Gravina, A.G.; Federico, A.; Giannini, E.G.; Bodini, G.
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies. Diseases 2024, 12, 295.
https://doi.org/10.3390/diseases12110295
AMA Style
Pasta A, Calabrese F, Marabotto E, Furnari M, Demarzo MG, Pellegrino R, Gravina AG, Federico A, Giannini EG, Bodini G.
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies. Diseases. 2024; 12(11):295.
https://doi.org/10.3390/diseases12110295
Chicago/Turabian Style
Pasta, Andrea, Francesco Calabrese, Elisa Marabotto, Manuele Furnari, Maria Giulia Demarzo, Raffaele Pellegrino, Antonietta Gerarda Gravina, Alessandro Federico, Edoardo Giovanni Giannini, and Giorgia Bodini.
2024. "Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies" Diseases 12, no. 11: 295.
https://doi.org/10.3390/diseases12110295
APA Style
Pasta, A., Calabrese, F., Marabotto, E., Furnari, M., Demarzo, M. G., Pellegrino, R., Gravina, A. G., Federico, A., Giannini, E. G., & Bodini, G.
(2024). Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies. Diseases, 12(11), 295.
https://doi.org/10.3390/diseases12110295
